Partner Content Partner Content Measuring Advocacy of Digital KOLs Identifying the most important & active digital experts in your space is just the first step of the engagement planning cycle.
Partner Content Partner Content Understanding Adherence: 5 Questions Patients Want to Be Ask... Various factors impact treatment plan adherence
Partner Content Partner Content Improving KOL Virtual Advisory Board Engagements “Very satisfied” is the consensus of KOLs who participate in our SkyBoard virtual advisory board events.
Partner Content Partner Content Digital KOLs For Digital Engagement Digital KOL Identification and Engagement
Partner Content Partner Content KOL Influence Maps Who influences whom? Who’s connected to whom? Who collaborates with whom?
News NICE backs AZ/Ionis' Wainzua for ATTR polyneuropathy AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with ATTR polyneuropathy
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends